Distinctive patterns of early and late benign fibrosis are commonly observed after stereotactic ablative radiotherapy for lung malignancies. These changes on computed tomography scans need to be distinguished from so-called highrisk radiological features, which can be associated with a higher risk for tumor recurrence. This pictorial report illustrates the different radiological changes seen after stereotactic ablative radiotherapy delivered by using volumetric modulated radiotherapy, a technique that is being increasingly used in clinical care.
Introduction
Stereotactic ablative radiotherapy (SABR) is now an established treatment for patients with early-stage lung cancer. Evolving radiological changes are common after SABR, and the typical patterns seen can be subdivided into either acute or late radiological changes. Acute changes present within the first 6 months after SABR, and late radiological changes manifest at 6 months or later.
1,2 Acute radiological changes on computed tomography (CT) scan are subclassified into the following categories: diffuse consolidation, patchy consolidation, diffuse ground glass opacity (GGO), and patchy GGO. 1 Late radiological changes are categorized into a modified conventional pattern of fibrosis, scar-like fibrosis, and mass-like fibrosis. 1 The classification of patients into these groups is associated with modest interobserver agreement that appears to improve with training. 3 After SABR, radiological changes develop in most patients, 1, 4 but the frequency and timing of the radiological changes can vary depending on the SABR delivery technique used. 1, 5 We previously described the typical radiological changes developing in patients who had undergone SABR with an older fixed beam delivery approach. 1 The most frequent acute radiological changes seen after fixed beam delivery are diffuse consolidation (in 24% of patients) and patchy consolidation (in 21%), followed by diffuse GGO (8%) and patchy GGO (8%). 1 However, many institutions currently use volumetric modulated radiotherapy (VMAT) for SABR delivery, as it allows for faster treatments. 5 Late radiological changes are more common after VMAT, with the most frequent change being a modified conventional pattern (62%), which is a pattern characterized by consolidation, volume loss, and bronchiectasis. 5, 6 Occasionally, scar-like Diffuse ground glass opacity (GGO). A GGO is defined as a hazy increased opacity through which normal parenchymal structures (bronchi and vessels) can be visualized. Histopathological causes of GGO are partial filling of airspaces; alveolar wall (interstitial) thickening due to fluid, cells, or fibrosis; partial collapse of alveoli; increased capillary blood volume; or a combination of these, with the common factor being partial replacement of lung air. 13 A diffuse GGO is a GGO of more than 5 cm without consolidation. The involved region contains more GGO than normal lung. 1 In this figure, the diffuse GGO was seen at a more caudal aspect of the radiation field. SABR, stereotactic ablative radiotherapy; CT computed tomography. 
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Radiological Changes after SABR Figure 8 . Subpleural radiation fibrosis. Volumetric modulated radiotherapy plans typically attempt to reduce chest wall doses, leading to opacities parallel to the treated chest wall region. 2 SABR, stereotactic ablative radiotherapy; CT computed tomography. Figure 7 . Mass-like fibrosis. Mass-like fibrosis is defined as a well-circumscribed consolidation that is limited to the area of high-dose irradiation.
1 SABR, stereotactic ablative radiotherapy; CT computed tomography. Figure 9 . Air bronchograms. Visible air-filled bronchi (low attenuation) due to opacification of surrounding alveoli (high attenuation). The branching, linear lucencies appear when normally aerated pulmonary parenchyma is replaced by nonaerated tissue, either fluid or cellular material. 13 SABR, stereotactic ablative radiotherapy; CT computed tomography. Figure 10 . Enlarging opacity-a high-risk radiological feature. Enlarging lung abnormality with an increased density in the irradiated area that is due to either radiation-induced lung injury or recurrence of the tumor. SABR, stereotactic ablative radiotherapy; CT computed tomography. Figure 11 . Sequential enlargement-a high-risk radiological feature. An opacity that continues to enlarge on serial computed tomography (CT) scans. SABR, stereotactic ablative radiotherapy. Figure 12 . Craniocaudal growth-a high-risk radiological feature. Craniocaudal enlargement of an opacity (according to the Response Evaluation Criteria in Solid Tumors criteria, 5 mm and 20%). After SABR, most fibrosis is expected in the axial plane. Computed tomography (CT) changes in a craniocaudal direction is less likely to be related to radiation injury. 10 SABR, stereotactic ablative radiotherapy.
Radiological Changes after SABR Figure 13 . Bulging margin-a high-risk radiological feature. A new or persistent convexity arising in the irradiated lesion, where previously a straight or concave margin was present. 9 SABR, stereotactic ablative radiotherapy; CT computed tomography. Figure 14 . Loss of linear margins-a high-risk radiological feature. A previously straight margin to the fibrotic area is replaced by a convex surface. 9 SABR, stereotactic ablative radiotherapy; CT computed tomography. Figure 15 . Loss of air bronchogram-a high-risk radiological feature. Previously air-filled airways show new or increasing opacification. Loss of air bronchogram can signal tumor recurrence but is also observed in cases without local recurrence. [7] [8] [9] SABR, stereotactic ablative radiotherapy; CT computed tomography. (15%) or mass-like lung fibrosis (14%) is observed after SABR, with the latter being difficult to distinguish from a local recurrence. Several high-risk radiological features (HRFs) that may allow for the differentiation between fibrosis or tumor recurrence have been identified. [7] [8] [9] [10] [11] An HRF classification system was derived from a systematic literature review, and it included features such as an enlarging opacity, sequential enlarging opacity, craniocaudal growth, bulging margin, loss of linear margins, and loss of air bronchogram. 9, 11 However, in 50% or more of patients who did not subsequently experience local recurrence, some HRFs did develop after SABR. 4 Craniocaudal growth of the radiological masses develops in most patients with tumor recurrence. 9 The incidence of enlarging opacities in patients with and without recurrence are reported to range from 92% to between 33% and 65%. 4, 9, 11 The corresponding incidences of sequentially enlarging opacities were 67% and 0% to 14%. Features rarely seen in patients without subsequent recurrence were bulging margins (seen in 2%-17% of patients), linear margin disappearance (0%-2%), loss of air bronchogram (4%-5%), and craniocaudal growth (2%-17%). 4, 11 Recently, a Delphi consensus process by international opinion leaders in thoracic radiation oncology and radiology concluded that the findings suggestive of a local recurrence on CT scan were as follows: infiltration into adjacent structures, bulging margins, sustained growth, mass-like growth, spherical growth, craniocaudal growth, and loss of air bronchograms. 12 The Delphi consensus recommended use of FDG-PET/CT scans only when local recurrence was suspected.
With the increased use of SABR for both lung tumors and metastases, and as more specialists become involved in the care of long-term survivors, a more widespread knowledge of post-SABR radiological features is essential. We illustrate both acute and late radiological changes after VMAT SABR, as well as HRFs, in this brief report. We have selected images that highlight each feature in isolation so that clinicians can correctly interpret these features.
Methods
A prospective database of all patients treated with SABR at our institution was accessed to identify patients treated with VMAT SABR for early-stage lung cancer. Post-SABR CT scans were accessed in our radiological archives to identify representative acute and late radiological changes, and HRFs. All images and corresponding medical records of the selected cases were then reviewed by an experienced radiation oncologist. In selected cases, images of planning CT scans were superimposed with the dose color wash showing regions receiving 30 Gy or more to illustrate the dose-related changes.
Results
Typical radiological findings following SABR, as well as HRF's, are illustrated in Figures 1-15 .
Conclusion
As the number of long-term survivors after SABR for early-stage lung cancer increases, and as timely surgical salvage of local disease failure can result in cures, 14 all clinicians involved in follow-up of these patients should be familiar with the expected radiological features associated with SABR. Distinguishing benign changes on CT scans from possible recurrences will also avoid unnecessary patient anxiety and minimize the risks of toxicity from unnecessary diagnostic procedures.
